Profound Medical Corp. (NASDAQ:PROF) Q2 2025 Earnings Convention Name August 14, 2025 4:30 PM ET

Firm Contributors

Arun Swarup Menawat – Chairman of the Board & CEO
Mathieu Burtnyk – President
Rashed Dewan – Chief Monetary Officer
Stephen Kilmer – Investor Relations
Thomas Tamberrino – Chief Business Officer

Convention Name Contributors

Benjamin Charles Haynor – Lake Road Capital Markets, LLC, Analysis Division
Douglas W. Loe – Leede Monetary Inc., Analysis Division
John Glenn McAulay – Stifel, Nicolaus & Firm, Integrated, Analysis Division
Michael W. Freeman – Raymond James Ltd., Analysis Division
Scott McAuley – Paradigm Capital Inc., Analysis Division

Operator

Good day, everybody, and thanks for standing by. Welcome to the Profound Medical Second Quarter 2025 Monetary Outcomes Convention Name. [Operator Instructions] Please notice that immediately’s convention is being recorded.

I’ll now hand the convention over to your speaker host, Stephen Kilmer, Head of Investor Relations. Please go forward.

Stephen Kilmer

Thanks. Good afternoon, everybody.

Let me begin by stating that this convention name will embrace forward-looking statements inside the which means of relevant securities legal guidelines in america and Canada. All forward-looking statements are based mostly on Profound’s present beliefs, assumptions and expectations and relate to, amongst different issues, any expressed or implied statements relating to future monetary efficiency and place and expectations relating to the efficacy of Profound’s applied sciences within the remedy of prostate most cancers, BPH, uterine fibroids, palliative ache remedy and osteoid osteoma.

Such statements contain recognized and unknown dangers, uncertainties and different components which will trigger precise outcomes, efficiency or achievements to be materially totally different from these implied by such statements. No forward-looking assertion could be assured. Listeners are cautioned to not place undue reliance on these forward-looking statements, which communicate solely as of the date of this convention name. Profound undertakes no obligation to publicly replace or revise any forward-looking